Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
AVEVA Drug Delivery Systems, Inc.

AVEVA Drug Delivery Systems, Inc. Recalls

All product recalls associated with AVEVA Drug Delivery Systems, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Feb 2023

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–2 of 2 recalls

Buprenorphine Patch (AVEVA) – impurity specification failure (2023)

Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.

Class IIILow

FDAFeb 15, 2023Nationwide• AVEVA Drug Delivery Systems, Inc.

Buprenorphine Transdermal System (AVEVA) – Substance Impurity Concerns (2023)

Failed Impurities/Degradation Specifications: Out of specification for related substance 10-hydroxy buprenorphine N-Oxide results generated at the 18-month stability timepoint.

Class IIILow

FDAFeb 15, 2023Nationwide• AVEVA Drug Delivery Systems, Inc.